William D. Clark - Dec 31, 2021 Form 5 Insider Report for GENOCEA BIOSCIENCES, INC. (GNCA)

Role
President and CEO, Director
Signature
/s/ DIANTHA DUVALL, ATTORNEY-IN-FACT FOR WILLIAM CLARK
Stock symbol
GNCA
Transactions as of
Dec 31, 2021
Transactions value $
-$14,920
Form type
5
Date filed
3/16/2022, 05:28 PM
Previous filing
Dec 13, 2021
Next filing
Mar 17, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GNCA Common Stock Sale -$10.3K -3.79K -1.3% $2.71 288K Apr 2, 2021 Direct F1
transaction GNCA Common Stock Sale -$4.64K -2.08K -0.72% $2.23 286K Jun 1, 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Sale of shares by the Reporting Person to cover personal income tax withholding obligations in connection with the vesting and settlement of restricted stock units. Sell-to-cover is required by the Issuer, and this sale does not represent a discretionary transaction by the Reporting Person.